The following companies had unusual price changes in Sao Paulo trading. Stock symbols are in parentheses and prices are as of 4:15 p.m. New York time. Preferred shares are usually the most-traded class of stock.
The Bovespa Index rose 1.3 percent to 67,578.33.
Healthcare companies climbed after Credit Suisse Group AG said it has a “bullish” view on the industry in a report dated yesterday. Odontoprev SA (ODPV3) (ODPV3 BS) gained 4.3 percent to 24.46 reais. Fleury SA (FLRY3) (FLRY3 BS) increased 4.1 percent to 24.23 reais. Amil Participacoes SA (AMIL3) (AMIL3 BS) rose 2.7 percent to 18.89 reais.
Banco Indusval SA (IDVL3) (IDVL4 BS) jumped 9.4 percent to 8.75 reais, the most in almost two years. The bank, specializing in loans to mid-sized companies, is in talks with third parties to invest in the company, according to a regulatory filing. Indusval said it isn’t negotiating the sale of control and hasn’t signed any contracts yet.
OGX Petroleo & Gas Participacoes SA (OGXP3 BS) increased 5.5 percent to 19.58 reais. The oil company controlled by billionaire Eike Batista signed concession contracts for five exploration blocks in Colombia, according to a regulatory filing. The company also said it found hydrocarbons in its 3- OGX-36D-RJS well in Campos Basin off Brazil’s coast.
Petroleo Brasileiro SA (PETR4) (PETR4 BS) gained 1.2 percent to 28.33 reais. Mark Mobius, executive chairman of Templeton Asset Management Ltd.’s Emerging Markets Group, told clients in Johannesburg he is investing in energy companies such as Petroleo Brasileiro, as he expects the price of oil to remain above $100 a barrel.
Vale SA (VALE3) (VALE5 BS) fell 0.4 percent to 46.68 reais. Brazilian Finance Minister Guido Mantega asked shareholder Banco Bradesco SA to replace Roger Agnelli as chief executive officer of the iron-ore producer, newspaper O Estado de S. Paulo reported, without saying where it got the information. A Vale official in Rio de Janeiro, who declined to be named according to company policy, said the company has no comment.
To contact the editor responsible for this story: David Papadopoulos at firstname.lastname@example.org